Integer Holdings completed its acquisition by an affiliate of KKR-managed funds on Nov. 17, taking the medical-device contract manufacturer private in a transaction the company valued at approximately $5.7 billion, in enterprise value.

The completion announcement said shareholders would receive $127 a share in cash and Integer’s common stock had stopped trading on the New York Stock Exchange. Shareholders approved the transaction Oct. 21, following its Aug. 3 announcement.

Integer’s regulatory filing detailed a new credit agreement providing $2.1 billion in initial term loans and a revolving credit facility of up to $350 million. The revolving amount represents available credit, not a statement that it has all been borrowed. The company also said its previous credit agreement was repaid and terminated at closing.

Integer became a wholly owned subsidiary of Armstrong Parent, a KKR-fund affiliate, according to the filing. Its incumbent officers continued as officers, while Max Lin and Hunter Craig became directors of the surviving company.

The August agreement announcement followed a strategic review launched April 30. At that time, KKR said it intended to establish a broad-based employee ownership and engagement program after the acquisition. That was a plan, not confirmation that the program has now been implemented.